Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, APHP, Hôpital de la Pitié Salpêtrière, Paris, France.
Curr Opin Immunol. 2022 Feb;74:118-124. doi: 10.1016/j.coi.2021.11.006. Epub 2021 Dec 1.
In the central nervous system (CNS) parenchymal macrophages are called microglial cells and have a distinct developmental origin and can self-renew. However, during pathological conditions, when the blood-brain-barrier becomes leaky, including after injury, in multiple sclerosis or with glioblastoma, monocyte-derived macrophages (MDM) infiltrate the CNS and cohabit with microglia. In neurodegenerative diseases such as Alzheimer's disease or ALS, MDM mostly do not enter the CNS, and instead microglia take several identities. In the specific case of ALS, the affected motor neurons are even surrounded locally by microglia, while along the peripheral nerves, by MDM-derived macrophages. The specific functions and interactions of these different myeloid cells are only starting to be recognized, but hold high promise for more targeted therapies.
在中枢神经系统(CNS)实质细胞中的巨噬细胞被称为小胶质细胞,它们具有独特的发育起源,可以自我更新。然而,在病理条件下,当血脑屏障变得渗漏时,包括在损伤后、多发性硬化症或胶质母细胞瘤中,单核细胞衍生的巨噬细胞(MDM)会渗透到中枢神经系统并与小胶质细胞共存。在阿尔茨海默病或肌萎缩侧索硬化症等神经退行性疾病中,MDM 大多不会进入中枢神经系统,而小胶质细胞则具有几种身份。在肌萎缩侧索硬化症的特定情况下,受影响的运动神经元甚至被局部的小胶质细胞所包围,而在外周神经中,则由 MDM 衍生的巨噬细胞所包围。这些不同的髓样细胞的特定功能和相互作用才刚刚开始被认识,但为更有针对性的治疗提供了很高的前景。